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ABSTRACT Transbilayer migration of
membrane phospholipid arising from
membrane insertion of the terminal
human complement proteins has been
investigated. Asymmetric vesicles con-
taining pyrene-labeled phosphatidyl-
choline (pyrenePC) concentrated in the
inner monolayer were prepared by
outer monolayer exchange between
pyrenePC-containing large unilamellar
vesicles and excess (unlabeled) small
unilamellar vesicles, using bovine liver
phosphatidylcholine-specific exchange
protein. After depletion of pyrenePC
from the outer monolayer, the asym-
metric large unilamellar vesicles were
isolated by gel filtration and exposed to
the purified C5b-9 proteins at 370C.
Transbilayer exchange of phospholipid
between inner and outer monolayers
during C5b-9 assembly was monitored
by changes in pyrene excimer and
monomer fluorescence. Membrane de-
position of the C5b67 complex (by
incubation with C5b6 + C7) caused no
change in pyrenePC fluorescence.
Addition of C8 to the C5b67 vesicles
resulted in a dose-dependent de-
crease in the excimer/monomer ratio.
This change was observed both in the
presence and absence of complement
C9. No change in fluorescence was
observed for control vesicles exposed
to C8 (in the absence of membrane
C5b67), or upon C5b-9 addition to
vesicles containing pyrenePC symmet-
rically distributed between inner and
outer monolayers. These data suggest
that a transbilayer exchange of phos-
pholipid between inner and outer
monolayers is initiated upon C8 binding
to C5b67. The fluorescence data were
analyzed according to a "random
walk" model for excimer formation
developed for the case where py-
renePC is asymmetrically distributed
between lipid bilayers. Based on this
analysis, we estimate that a net transbi-
layer migration of /1% of total mem-
brane phospholipid is initiated upon C8
binding to C5b67. The potential signifi-
cance of this transbilayer exchange of
membrane phospholipid to the biologi-
cal activity of the terminal complement
proteins is considered.
INTRODUCTION
The membranolytic activity of the complement system
resides in a macromolecular complex composed of serum
proteins C5b6, C7, C8, and C9, bound to membrane
surfaces (reviewed in reference 1). This complex not only
mediates immune cytolysis, but can also elicit nonlytic
stimulatory responses resulting in cell activation (2-6).
For example, human blood platelets exposed to the C5b-9
proteins are stimulated to secrete from intracellular stor-
age granules and to express de novo binding sites for
coagulation factor Va, initiating assembly of the pro-
thrombinase enzyme complex of factors VaXa (7-9).
This results in prothrombin conversion to thrombin and
accelerated plasma clot formation. These observations
suggest that platelet activation by the C5b-9 proteins
results in increased exposure of acidic phospholipids on
the platelet surface, providing negatively charged sites for
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membrane binding of factor Va (9-12). Transbilayer
migration of acidic phospholipid from inner to outer
monolayer of the plasma membrane has been demon-
strated after platelet activation by calcium ionophore and
collagen (10-13), raising the possibility that increased
factor Va binding to C5b-9 platelets arises from cell
activation mediated through increased cytosolic calcium.
Alternatively, the C5b-9 proteins potentially affect the
transmembrane distribution of phospholipid by directly
altering lipid bilayer organization, for example, by cre-
ating local domains of nonbilayer lipid (14).
To determine whether the membrane inserted C5b-9
proteins directly catalyze transbilayer migration of phos-
pholipids, we have examined the interaction of these
proteins with unilamellar lipid vesicles under conditions
permitting real-time determination of the transbilayer
distribution of membrane phospholipid. Because the
membrane permeability changes that are known to arise
upon assembly of the C5b-9 complex precluded use of
aqueous labeling reagents to assess phospholipid asymme-
try, we have developed a method for directly assessing
transbilayer distribution of a fluorescently labeled phos-
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pholipid, using a modification of the method of Everett et
al. (15). In these experiments, changes in pyrene excimer
and monomer fluorescence during assembly of the C5b-9
complex are employed to monitor the transbilayer migra-
tion of a pyrene-labeled phosphatidylcholine initially con-
centrated in the inner monolayer.
MATERIALS AND METHODS
Materials
3-Palmitoyl-2-( 1-pyrenedecanoyl)-L-a-phosphatidylcholine (pyrene-
PC)' was obtained from Molecular Probes Inc., Eugene, OR; L-
a-lecithin and phosphatidylserine (disodium salt) from bovine brain
were obtained from Avanti Polar Lipids, Inc., Birmingham, AL. All
other chemicals were of reagent or analytical grade.
Solution
Na-TES: 10 mM 2-((tris-(hydroxymethyl)-methyl)-amino)ethane sul-
fonic acid, 50 mM NaCl, 1 mM ethylenediamine tetraacetic acid, 0.02%
(wt/vol) NaN3, pH 7.4.
Exchange protein
Phosphatidylcholine-specific phospholipid exchange protein (PCEP)
was isolated according to published methods (16) and assayed according
to the methods of Brown et al. ( 17). The protein was stored at - 200C in
50% (vol/vol) glycerin, and dialyzed into Na-TES immediately before
use.
Preparation of vesicles
Small unilamellar vesicles (SUV) were prepared according to Barenholz
et al. (18). Large unilamellar vesicles (LUV) were prepared by deter-
gent dialysis (19).
Preparation of asymmetric
vesicles
Large unilamellar vesicles containing pyrenePC asymmetrically con-
centrated in the inner monolayer (ALUV) were prepared using a
modification of the method introduced by Everett et al. (15). LUV
containing 20 mol % pyrenePC were incubated (370C, 24 h) with a
37-fold molar excess of SUV (5% phosphatidylserine, 95% phosphati-
dylcholine) in the presence of 122 ,g/ml PCEP. Total lipid concentra-
tion was 29.4 mM (28.6 mM in small vesicles, 0.8 mM in large vesicles)
in a total volume of 1 ml. After exchange, the large vesicles were
separated from protein and small vesicles by gel filtration on Sepharose
CL-2B (0.9 x 27 cm). Eluted fractions (1.16 ml) were assayed for total
phospholipid (20) and pyrenePC (see below). The peak fraction of lipid
'Abbreviations used in this paper: ALUV, asymmetric large unilamel-
lar lipid vesicle; E, pyrene excimer fluorescence; LUV, large unilamellar
lipid vesicle; M, pyrene monomer fluorescence; mf, mole fraction of
pyrenePC; PCEP, phosphatidylcholine-specific phospholipid exchange
protein; pyrenePC, 3-palmitoyl-2-( 1-pyrenedecanoyl)-L-a-phosphati-
dylcholine.
eluting in the void volume was analyzed and used immediately. Contam-
ination of large vesicles by aggregated small vesicles eluting in the void
volume of the column was estimated to be <3% by phospholipid (data
not shown).
Determination of pyrenePC
concentration
PyrenePC concentrations of labeled vesicles were measured by a modifi-
cation of the method of Van Den Zegel et al. (21). Samples were
dissolved in 1% sodium dodecyl sulfate, incubated 1 h at 370C, and
transferred to a cuvette for measurement of fluorescence intensity (at
378 nm). Comparison was made to the measured fluorescence emission
of standards of pyrenePC (0-5 ,uM) hydrated in 1% sodium dodecyl
sulfate. Concentrations of the pyrenePC standards was based on phos-
phorus determination (20). The purity of the pyrenePC was confirmed
by thin-layer chromatography on silica gel plates in the solvent system
chloroform/methanol/water (65:25:4).
Complement proteins
Human complement proteins C5b6, C7, C8, and C9 were purified and
assayed with the following modification of methods previously described
(22-24): C5b6 was subject to additional purification by ion exchange on
Mono Q (Pharmacia Fine Chemicals, Piscataway, NJ), performed at
pH 8 in the presence of 10% glycerol. C7 was purified using monoclonal
immunoaffinity chromatography, followed by ion exchange chromatog-
raphy on Mono Q. To exclude possible trace contaminating C9, purified
C8 was absorbed with monospecific antibody (goat) to human C9,
coupled to Sepharose CL-4B.
C5b67 vesicles
Membrane bound CSb67 complexes were prepared by mixing vesicles
with C5b6 followed by the addition of C7 with rapid mixing. Final
concentrations were 0.26 mM lipid, 0.25 mg/ml C5b6, and 0.05 mg/ml
C7 except when specified otherwise. After 5 min incubation at room
temperature the mixture was stored on ice and used within 60 min.
C5b-9 assembly
C5b-9 assembly was initiated by C8 and C9 addition to C5b67 vesicles
suspended in a stirred fluorescence cuvette equilibrated at 370C. C5b67
vesicles were diluted in Na-TES to yield a final lipid concentration of 1.9
AtM. After 5 min equilibration, C8 (0-10 ,g/ml) and/or C9 (0-16
Ag/ml) were added as described in figure legends. Fluorescence was
continuously monitored before and after protein additions (below).
Fluorescence spectroscopy
All fluorescence measurements were obtained with a SLM8000C
photon-counting Spectrofluorometer equipped for sample stirring and
temperature control. Excitation was provided by a xenon arc lamp and
emission detected by model R928P photomultiplier tubes (Hamamatsu
Corp., Middlesex, NJ). Wavelength selection was provided by a double
grating excitation monochromator and single grating emission mono-
chromators arranged in T-format. To reduce photobleaching, shutters
were closed except during data acquisition; 1 cm pathlength quartz
cuvettes containing 1.5-2.5 ml volume of sample were employed
throughout. Unless otherwise indicated, spectra were recorded with an
excitation bandwidth of 2 nm, emission bandwidth of 4 nm and the
non
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excitation monochromator was set at 345 nm. All data were corrected
for dilution due to additions to the cuvette, and for the wavelength-
dependent response of the instrument, using correction factors supplied
by the manufacturer.
DATA ANALYSIS
Dependence of pyrene excimer
formation on probe concentration
when pyrenePC is symmetrically
distributed across bilayer
As discussed by Eisinger et al. (25), three models are
available to describe the relationship of pyrene excimer
(E) and monomer (M) intensities to the mole fraction of
pyrenePC (mf) incorporated into a lipid bilayer: a "diffu-
sion" model (25), a "random walk" model (26, 27), and a
"milling crowd" model (25). To determine the most
appropriate model to account for the concentration-
dependent change in E and M observed for pyrenePC
under our experimental conditions, we first measured the
dependence ofE and Mon the mole fraction of pyrenePC
(mf) when the probe lipid was symmetrically incorpo-
rated into large lipid vesicles, by hydration and detergent
dialysis of premixed labeled and unlabeled lipids (see
above). We found that the experimentally determined
E/M vs. mf deviated from linearity for mf > 0. 1, indicat-
ing that the diffusion model (25) cannot be applied for
pyrenePC under our conditions (Fig. 1). Similar results
for a pyrene-labeled glucocerebroside incorporated in
lipid vesicles have been reported by Thompson and asso-
ciates (28). By contrast, when evaluated according to a
random walk model (Fig. 2), the data we obtained were in
good agreement with the predicted relationship of E and
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FIGURE I Dependence of E/M on mole fraction of pyrenePC. E/M
was measured (at 370C) for a series of vesicles containing varying
amounts of pyrenePC (mole fraction pyrenePC indicated on abscissa),
and analyzed according to the diffusion model (reference 25). Line
represents a least squares fit through the origin according to diffusion
model, for data with mf < 0.1 (see Data Analysis in Materials and
Methods).
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FIGURE 2 Fit of experimental data to random walk model. Data refer
to the series of vesicles described in Fig. 1, analyzed according to Eqs. 1
and 2 (random walk model; see Data Analysis, Materials and Methods).
(A) Measured E/M plotted as function of Z (from Eqs. 1 and 2). Line
represents least-squares fit of the data through the origin (r2 - 0.98).
From the reciprocal of the slope of the regression line, C/L - 0.046 ±
0.006. (B) Monomer fluorescence plotted as (mf * Q)/M vs. Z (see Eq.
1); r2 - 0.98. Parameter V (defined in Data Analysis, Materials and
Methods) derived from best fit of the data equals 0.0026 ± 0.0012. (C)
Excimer fluorescence plotted as (mf * Q)/E vs. 1/Z (see Eq. 2); r2
0.87. V - 0.0022 ± 0.0002.
M to mf, given by the following equations (adapted from
reference 25):
M=mf*Q*L* V/(V+ Z)
E = mf * Q* C*Z/(V+ Z),
(1)
(2)
where Q is the total lipid concentration, L and C are
proportionality constants, and Z is related to mf by
Z = mf/ In (2/mf). (3)
V (in Eqs. 1 and 2) is that value of Z for which the
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monomer and excimer yields are half-maximal. For these
symmetrically distributed pyrenePC LUV (before PCEP-
catalyzed exchange), we determined that V = 0.0022 +
0.0002 and C/L = 0.046 ± 0.006, for mf between 0 and
0.25. Because of the satisfactory fit of our data to the
random walk model (Fig. 2), we have not further ana-
lyzed these data according to the generalized milling
crowd model, developed by Eisinger et al. (25).
Dependence of pyrene excimer
formation on probe concentration
when pyrenePC is asymmetrically
distributed across the bilayer
To deduce the quantitative change in the distribution of
pyrenePC between inner and outer monolayers of the
ALUV employed in our experiments, we considered the
process of pyrene excimer formation for the case that
pyrenePC is asymmetrically distributed across the bilayer
(i.e., when the mole fraction of pyrenePC in the inner
monolayer [mU.1n] is not equal to that in the outer mono-
layer [mf.0ut]).
Model 1: pyrene excimer formation
restricted to in-plane interactions
within each monolayer
In this model we assume that pyrene excimers can only
form between pyrenePC located in the same monolayer.
According to this model, E and M are related to the mole
fraction of pyrenePC by the following equations:
The ratio of phospholipid in outer and inner monolayers
(Qout/Qin) of the ALUV employed in our experiments can
be estimated from the change in total probe concentration
when pyrenePC is removed from the outer monolayer (see
Table 1 in Results). As these data indicate, the amount of
pyrenePC in the vesicles decreases from 0.151 ,mol (of a
total of 0.75 ,umol phospholipid before PCEP-catalyzed
exchange) to 0.072 ,umol (of a total of 0.74 ,tmol phos-
pholipid after exchange and gel filtration). Assuming that
pyrenePC is (a) distributed symmetrically across the
monolayers of the initial vesicles formed during detergent
dialysis and (b) removed only from the outer monolayer
of the LUV during PCEP-catalyzed exchange with unla-
beled SUV (described above), these data indicate that the
ratio of total lipid in outer/inner monolayers of the large
vesicles used in these experiments, Qout,/Qin = 1.1. This
result is in good agreement with the predicted mass
distribution between monolayers, based on consideration
of the radius of curvature of LUV formed by detergent
dialysis (reviewed by reference 29). Using this value of
Qout/Qin, Eq. 8 can be used to predict the relationship
between E/M and mf.0ut as pyrenePC redistributes from
the inner to outer monolayer of the ALUV formed under
our experimental conditions (Fig. 3 solid curve).
For asymmetric LUV prepared by PCEP-catalyzed
depletion of the outer monolayer of 20 mol% (initial)
pyrenePC vesicles (described above), the measured E/M
(1. 19) suggests a distribution of pyrenePC between LUV
monolayers of mf...t = 0.003, mfin = 0.197 (from Eq. 8
M = [mf. * Qin * L * V/(V + Zin)]
+ [mf.ot * Qout * L * V/(V + ZOut)] (4)
E = [mf. * Qin * C * Zi,, /(V + Zin)]
+ [mf.ot * Qot * C * Zout /(V + Zot))], (5)
LuJ
where L, V, and C are the constants introduced above, Qi,,
is the molar lipid concentration accounted for by inner
monolayer lipid and Qout is the molar lipid concentration
accounted for by outer monolayer lipid. Zin and Z.., are
each related to the respective mole fraction of pyrenePC
in the inner and outer monolayers by
Zin mfr,/ ln [2/mf.n] (6)
ZO,,,= mf.Out/ In [2/mfrt]. (7)
Combining Eqs. 4 and 5, E/M can be expressed as
EIM = (C/LV) * (NID), (8)
where
N = [(Mfin * ZJ)/(V + Zin)]
+ [(Qot/Qin) * (Mf.out * Zout)/(V + Zout)]
D = [Mfin/(V + Zin )] + [Qout/Qin) * (Mfout/(V + Zout) ]
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FIGURE 3 Dependence of pyrene excimer formation on the distribution
of pyrenePC between monolayers. Solid curve depicts the theoretical
relationship of E/M (ordinate) to mf,., (abscissa) based on Eq. 8, for
V- 0.0022, C/L = 0.046, and QO.Jt/QU - 1.1 (model I; see Data
Analysis in Materials and Methods). Curve is drawn for asymmetric
large unilamellar vesicle containing 9 mol% pyrenePC (pyrenePC/total
lipid). Dotted curve depicts the theoretical relationship ofE/M to mf.O.
based on Eq. 11, for C/LV - 13.8, C'/LV - 7.2, V - V' - 0.0022, and
Q..tlQi ~=1.1 (model 2; see Data Analysis in Materials and Methods).
Dashed lines denote experimental EIM measured for asymmetric LUV
prepared by depletion of probe from the outer monolayer of an initial 20
mol% pyrenePC LUV (see text).
938 Biophysical Journal Volume 56 November
U.UUU
Biophysical Journal Volume 56 November 1989
using coefficients Qout/Qin = 1.1; V = 0.0022; C/L
0.046; see above). These values are depicted by dashed
lines in Fig. 3. Note that this estimate is close to the
predicted transbilayer distribution of pyrenePC at the end
of PCEP-catalyzed exchange between 20 mol% pyrenePC
(symmetric) LUV and a 37-fold molar excess of unla-
beled SUV, as under our experimental conditions.
Model 2: pyrene excimer formation
by both in-plane and transbilayer
interactions of pyrenePC
As noted above, the formulation of model 1 assumes that
pyrene excimers form only by in-plane interaction of
pyrenePC distributed within the same monolayer, and
that the observed E/M represents the contribution of
excimers arising independently in each monolayer.
According to this model, the discrepancy between the
experimental E/M observed in asymmetric bilayers gen-
erated by depletion of pyrenePC from the outer mono-
layer (E/M = 1.19; fraction 6 of Fig. 4) from that of the
initial symmetric pyrenePC containing LUV (E/M =
1.85 before PLEP-catalyzed exchange) reflects the fluo-
rescence of a small amount of pyrenePC that remains in
the outer monolayer of the newly formed asymmetric
LUV. An alternative interpretation of these results is that
excimer formation in each monolayer is not strictly
independent, and that excimers can also arise by interac-
tion between pyrenePC distributed in apposing mono-
layers. Because of the uncertainties inherent to preparing
(and maintaining) asymmetric LUV completely devoid of
pyrenePC in the outer monolayer, we were unable to
unambiguously exclude this latter possibility. Neverthe-
less, an upper limit to the potential contribution of such a
transbilayer excimer-forming process can be obtained by
assuming that the observed discrepancy in the EIM of
asymmetric vs. symmetric LUV is totally accounted for
by the loss of transbilayer excimers when pyrenePC is
removed from the outer monolayer. In this model, we
assume that pyrene excimers can form in two ways, (a)
between pyrenePC in the same monolayer (i.e., in-plane
excimer formation) and (b) between pyrenePC in appos-
ing monolayers (i.e., transbilayer excimer formation). In
this model, E and M are given by:
M= Mn *Qin L VV + Zin)]
+ [mfot * Qot * L * V/(V + Zout)] (9)
E= [Mn *Qin *c* Zn/(V + ZiJ)]
+ fot * Qot* C * Zot/(V + Zou)]
+ [Mf.in *Qin * C' * Zout/(V + Zout)I
+ [MOut *Qout * C' * Zin/(V' + Zin)J, (O0)
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FIGURE 4 Gel permeation chromatography of asymmetric pyrenePC-
containing LUV. Sepharose CL-2B elution profile of exchange mixture
containing pyrene-PC LUV and unlabeled SUV after incubation with
PCEP. (A) Total lipid phosphorus (nanomoles). (B) PyrenePC (nano-
moles). (C) Relative fluorescence intensity of pyrene excimer, measured
at 470 nm (arbitrary units). (D) Relative fluorescence intensity of
pyrene monomer, measured at 378 nm (arbitrary units). (E) Ratio of
excimer/monomer intensities. Fluorescence data were obtained at room
temperature and corrected for temperature dependence and instrument
response. See Materials and Methods.
where C of model 2 is now a constant proportional to the
probability of pyrene excimer formation by in-plane
(intramonolayer) interaction and C' is a constant propor-
tional to the probability of transbilayer excimer forma-
tion. V of model 2 is now that value of Zi. at which the
in-plane excimer formation is half-maximal, and V' is the
equivalent parameter for the process of transbilayer
excimer formation. It should be noted that the constants
introduced in model 2 are not necessarily numerically
equivalent to the analogous constants employed in model
50
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1. Combining Eqs. 9 and 10,
EIM= [(C/LV) * (N) + (C'/LV) * (N')]/D, (11)
where N and D are defined as in Eq. 8 (above) and N' =
I(Mf.in * Zout)/(V' + Zout )] + [(Qout/Qin) * (Mtout * Zin)/
(V' + Zin)]. In the case of symmetrically distributed
pyrenePC, Mf.in = Mfout = mf, Zin =Zout = Z, and Eq. 11
condenses to:
E/M =Z [C/LV + (C'/LV) * (V + Z)/(V' + Z)]. (12)
When pyrenePC is symmetrically distributed across the
bilayer, measured E/M is observed to be linearly related
to Z (see Fig. 2 A), implying from Eq. 12 that V V'.
Consequently, in this case (where pyrenePC is symmetri-
cally distributed across the bilayer), Eq. 12 simplifies to
EIM = Z * (C/LV + C'/LV). (13)
Using the data of Fig. 2 A to solve for the coefficient of
Eq. 13, we estimate (C/LV + C'/LV) = 21.
After total removal of pyrenePC from the outer mono-
layer (Zut = mf..t = 0), the possibility of transbilayer
excimer formation is precluded, and the relationship
between E/M and Z in the resulting asymmetric vesicle
can be expressed by
EIM = Zin * (C/LV), (14)
where Z = Zin (before any redistribution of pyrenePC
from inner to outer monolayers). For vesicles containing
an initial 20 mol% pyrenePC (i.e., Z = 0.087; see Eq. 3),
the measured E/M was observed to decrease from
E/M = 1.85 (in the initial LUV formed by detergent
dialysis) to E/M = 1.19 (after depletion of outer mono-
layer pyrenePC by PCEP-catalyzed exchange and gel
filtration; data not shown). By substituting these values of
E/M into Eqs. 13 and 14, respectively, and setting
(C/LV + C'/LV) = 21 (see above), the coefficients
(C/LV) and (C'/LV) can be directly solved: C/LV =
13.8 and C'/LV = 7.2. Based on the estimated mass
relationship of outer and inner monolayers for these large
vesicles (Qot/Qin = 1.1; see above), the numerical solu-
tions to these coefficients can then be used to derive the
relationship of E/M to mf.Out predicted by Eq. 11 (dotted
curve in Fig. 3).
Inspection of the two curves depicted in Fig. 3 reveals
that when one allows for the possibility of a transbilayer
pyrene excimer (i.e., dotted curve predicted by model 2),
there is less than a twofold change in the initial slope of
E/M vs. mf.00t from that predicted when one assumes
complete independence of excimer formation in each
monolayer (solid curve predicted by model 1). These data
therefore suggest that intramonolayer pyrenePC excimer
formation is dominant to the transbilayer process
(C/C' = 2), the latter process presumably requiring
interdigitation of the acyl chain-tethered pyrenes. Also to
be noted, model 1 (which excludes transbilayer excimer
formation) and model 2 (which assumes transbilayer
excimer formation) refer to limiting cases, and the actual
relationship ofE/M to mf..ut is likely to be intermediate to
the two curves plotted in Fig. 3. According to both
models, when mfo., < 0.01, the measured E/M is pre-
dicted to be extremely sensitive to changes in mf.Out arising
from subsequent transbilayer phospholipid exchange (re-
sulting in equilibration of pyrenePC from the inner to
outer monolayers).
RESULTS
The distribution of total phospholipid and pyrenePC
between LUV and SUV after incubation with PCEP and
chromatography over Sepharose CL-2B are summarized
in Table 1 and Fig. 4. LUV (eluting in the void volume)
contained 99% of initial phospholipid (added as large
vesicles to the exchange mixture) and 48% of their initial
pyrenePC. Assuming a symmetric distribution of py-
renePC between inner and outer monolayers of LUV
(before exchange), these data suggest near complete
depletion of pyrenePC from the LUV outer monolayer
(see Data Analysis, Materials and Methods). Consistent
with this interpretation, the ratio of excimer/monomer
intensities of the peak fraction of large vesicles eluting
from the column (E/M = 1.19) indicates that the vesicles
retain nearly 20 mol% pyrenePC in the inner monolayer,
<0.3 mol% pyrenePC remaining in the outer monolayer
(see Data Analysis and Fig. 3, Materials and Methods).
When spontaneous transbilayer exchange was induced by
heating (1 h, 850C), E/M decreased to 0.83 (data not
shown), consistent with a decrease in mole fraction of
pyrenePC in the inner monolayer due to redistribution of
the probe from inner to outer monolayers.
TABLE 1 Analysis of vesicles eluting from Sepharose
CL-2B
Before exchange After exchange
Amol gmol
Phospholipid in large vesicles 0.75 0.740*
Phospholipid in small vesicles 27.9 28.0t
PyrenePC in large vesicles 0.151 0.072*
PyrenePC in small vesicles (0) 0.0664:
Phospholipid (measured as total phosphorous) and pyrenePC in large
and small vesicle pools, before and after exchange catalyzed by PCEP.
Exchange conditions were as described in Materials and Methods.
*Refers to ALUV eluting in void volume (pool of fractions 5-7 eluting
from Sepharose CL-2B; Fig. 4).
tPool of fractions 8-19 eluting from Sepharose CL-2B; Fig. 4.
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Changes in pyrenePC
fluorescence due to C5b-9
assembly
To determine whether membrane insertion of the termi-
nal complement proteins is accompanied by a redistribu-
tion of phospholipid between inner and outer monolayers,
these asymmetric pyrenePC-containing LUV (ALUV)
were exposed to the purified C5b-9 proteins and moni-
tored for changes in pyrene excimer/monomer intensities
(Table 2 and Figs. 5-8). No change in E/M from control
values was observed upon deposition of the membrane
C5b67 complex (by incubation of vesicles with C5b6 +
C7 without added C8 or C9; Table 2). By contrast,
formation of the C5b-9 complex (by addition of C8 + C9
to C5b67 ALUV) resulted in an approximate 8%
decrease in E/M (Table 2). This change in E/M was also
observed upon C8 addition to C5b67 ALUV (in the
absence of C9), but was not observed upon C8 addition to
ALUV lacking preformed C5b67 complexes.
The change in E/M upon assembly of the membrane
attack complex was found to depend upon both the
number of preformed C5b67 sites (as varied by changing
the initial input of C5b6; Fig. 5) as well as upon the input
of C8 (to ALUV expressing a constant number of preas-
TABLE 2 Change In pyrenePC fluorescence due to
membrane assembly of the terminal complement
proteins
Vesicles* Treatmentt Change in E/IM
ALUV C5b6, C7, C8,1 C9 -7.9 ± 0.8 (n - 3)1
ALUV C5b6, C7, C81 -8.4 ± 1.2 (n = 5)'
ALUV C5b6, C7, C8 - 6.4 ± 0.8 (n = 14)'
ALUV C5b6, C8 0.07 ± 0.4 (n - 3)
ALUV C7, C8 -0.03 ± 0.4 (n = 3)
Symmetric C5b6, C7, C8, C9 -0.01 ± 0.01 (n - 3)
Symmetric C5b6, C7, C8 0.5 ± 1.7 (n - 3)
Symmetric** C5b6, C7, C8 -0.3 ± 1.9 (n - 3)
*Symmetric LUV (20% pyrenePC) and asymmetric ALUV (20%
pyrenePC in inner monolayer only) were prepared as described in
Materials and Methods and used at 0.26 mM (final concentration in
cuvette).
tVesicles were incubated with C5b6 (0 or 0.25 mg/ml), C7 (0 or 0.05
mg/ml), C8 (0 or 5 Mg/ml), and C9 (0 or 16 tsg/ml) under conditions
described in Materials and Methods.
'Mean ± SD. Change in E/M represents the response measured upon
addition of C8, expressed as a percentage of the initial value. E/M
measured for C5b67 ALUV (in absence of C8) did not significantly
differ from that measured for controls (omitting C5b6 or C7; see
Materials and Methods).
IC8 was added at 10,ug/ml.
'Significant vs. complement-free control, P < 0.05.
**ALUV were incubated for 1 h at 850C to induce spontaneous
transbilayer redistribution of pyrenePC before exposure to complement
proteins.
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FIGURE 5 Loss of pyrenePC asymmetry upon C5b-9 assembly: rela-
tionship to input of C5b6. Asymmetric LUV (0.22 mM total lipid; imole
fraction of pyrenePC in inner monolayer - 0.197) were exposed to C7
(40 ,g/ml) plus amounts of C5b6 indicated (abscissa). After 5 min at
230C, an aliquot was diluted and equilibrated at 370C in a stirred
cuvette for fluorescence measurements (final lipid concentration, 2.1
,uM). Plotted is the change in excimer/monomer fluorescence measured
upon addition of C8 (5 Ag/ml). Data are representative of two similar
experiments performed on separate days.
sembled C5b67 complexes; Fig. 6). Furthermore, no sig-
nificant difference in the C8 dose-dependent change in
E/M was observed when experiments were performed
either in the presence (Fig. 6 A) or absence (Fig. 6 B) of
saturating amounts of C9 (see also Table 2), suggesting
that this change in E/M occurs when C8 binds to the
membrane C5b67 complex (see Discussion). This change
in E/M observed for C5b-8-treated ALUV was detected
within seconds of C8 addition, and reached completion
within 1 min (Fig. 7).
Relationship of change in E/Mto
transbilayer exchange of
pyrenePC
The change in E/M detected upon C8 binding to mem-
brane C5b67 suggests a decrease in the concentration of
pyrenePC in the inner monolayer arising from exchange
with unlabeled lipid in the outer monolayer (see Data
Analysis and Fig. 3; Materials and Methods). Alterna-
tively, this spectral change could potentially reflect a
change in either the local environment or the mobility,
orientation, or lateral distribution of the chromophore
arising upon C8 binding and insertion into the membrane
(25-27). As illustrated in Table 2, no change in E/M was
observed when C5b-8 (or C5b-9) was assembled on LUV
containing pyrenePC symmetrically distributed between
inner and outer monolayers. A similar result was obtained
when ALUV were first allowed to spontaneously equili-
brate pyrenePC between monolayers before exposure to
the terminal complement proteins (Table 2). These data
suggest that the decrease in EIM observed upon mem-
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FIGURE 6 Loss of pyrenePC asymmetry upon C5b-9 assembly: depen-
dence on C8. Asymmetric pyrenePC-containing LUV (0.22 mM phos-
pholipid) were pretreated with C5b6 (0.25 mg/ml) plus C7 (40 Mg/ml)
before dilution and suspension at 37°C for fluorescence measurements.
Plotted is the change in pyrene excimer/monomer intensity (percent
change from initial value) measured upon addition of C8 at concentra-
tions indicated (abscissa). (A) Data obtained in the absence of C9. (B)
Data obtained in the presence of 5 ,ug/ml C9, added immediately before
C8 additions. Data plotted as mean ± SD of three to nine determina-
tions at each C8 concentration. Curves represent the least-squares fit of
the data to the following equation: change in E/M (%) - D * [C8]/
([C8] + K). For A, D - 7.96 and K - 0.40 ;g/ml; For B, D - 7.70 and
K = 0.42 Ag/ml. Analysis by Students t-test indicates no significant
difference between data of A vs. B at each concentration indicated
(P > 0.2).
brane assembly of the C5b-8 complex is not due to
changes in fluorescence secondary to perturbation of
pyrenePC located in either inner or outer monolayers, but
represents the change in pyrenePC concentration in each
monolayer that is predicted when this lipid redistributes
across the bilayer.
In addition to potential artifacts arising from changes
in probe environment or orientation that might directly
affect pyrene excimer and monomer intensities, we con-
sidered the possibility that the apparent decrease in the
concentration of pyrenePC distributed in the inner mono-
layer ofALUV exposed to the complement proteins arose
FIGURE 7 Rate of change in E/M upon C5b-8 assembly. The time-
dependent change in the ratio of pyrene excimer/monomer fluorescence
(E/M) is shown for C5b67 ALUV exposed to 5 Mg/ml C8 (open
symbols). C8 was added at time indicated by arrow. Change in E/M for
controls (lacking C7) is also shown (solid symbols). C5b67 assembly
was performed as described in Fig. 6. Data representative of three
separate experiments performed under identical conditions.
from a complement-induced fusion of these vesicles. To
address this possibility, LUV containing 20 mol% py-
renePC (symmetrically distributed) were mixed with an
equal number of unlabeled LUV, and then C5b-9
assembly initiated. Under these conditions, no change in
E/M was detected, whereas fusion and mixing of lipid
(induced by light sonication) showed the expected
decrease in E/M (data not shown).
Comparison of the emission spectra of C5b67 vs. C5b-8
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FIGURE 8 Fluorescence emission spectra of complement-treated asym-
metric LUV. Fluorescence emission spectra measured before (solid
line) and after (dotted line) addition of 10 jg/ml C8 to C5b67 ALUV.
Excitation was at 345 nm. C5b67 assembly was performed as described
for Fig. 6.
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ALUV suggests that virtually all of the change in E/M
upon C8 binding arises from an increase in monomer
emission (at 378 nm), with virtually no change in excimer
emission (at 470 nm) detected (Fig. 8). This result is in
agreement with the expected change in excimer and
monomer yields arising from a decrease in the concentra-
tion of pyrenePC in the inner monolayer (initially at -20
mol%) through exchange with phospholipid in the outer
monolayer (<0.3 mol% pyrenePC). According to Eqs. 4
and 5 (model 1) or Eqs. 9 and 10 (model 2; see Data
Analysis in Materials and Methods), an 8% increase in
monomer emission due to transbilayer exchange or py-
renePC under these conditions is predicted to decrease
excimer emission by only 0.3% (cf. data of Fig. 8).
DISCUSSION
The results of these experiments suggest that membrane
assembly of the terminal complement proteins is accom-
panied by a redistribution of lipid between inner and outer
monolayers. Furthermore these data suggest that this
transbilayer migration is initiated upon C8 binding to the
membrane C5b67 complex, independent of subsequent
incorporation of C9. These results therefore provide evi-
dence that in addition to modifying membrane permeabil-
ity to aqueous solute, insertion of these pore-forming
serum proteins can directly affect the physical properties
of the membrane surface, specifically through changes in
the phospholipid composition of the outer monolayer.
Wiedmer et al. have previously shown that human
platelets treated with the C5b-9 proteins express de novo
binding sites for coagulation factor Va and exhibit
increased prothrombinase activity which can accelerate
plasma clotting (7, 8). Because surface-expressed acidic
phospholipid is thought to provide the catalytic surface
required for assembly of the platelet prothrombinase
enzyme complex (VaXa), these results suggested that the
C5b-9 proteins induce transbilayer exchange of phospha-
tidylserine from the inner to outer monolayer of the
platelet plasma membrane, either through stimulatory
mechanisms associated with platelet activation, or
through direct effects of the complement proteins on
membrane bilayer configuration (9). Evidence for trans-
bilayer migration of phosphatidylserine from inner to
outer monolayers due to cell activation by collagen and
other platelet agonists has previously been described
(10-12). The data of the present study suggest that for
cells exposed to the activated complement proteins,
increased factor Va binding may also arise due to the
direct effects of the terminal complement proteins on
transbilayer phospholipid asymmetry, irrespective of con-
comitant C5b-9-induced activation of the cell's stimula-
tory pathways.
Analysis of the data of Table 2 and Fig. 6 according to
Eq. 8 (model 1) or Eq. 11 (model 2; see Data Analysis in
Materials and Methods) suggests that under the condi-
tions of our experiments, maximally 0.09% (model 2) to
0.14% (model 1) of total pyrenePC is translocated from
inner to outer monolayers upon C8 binding to membrane
C5b67. Because in our experiments pyrenePC initially
constitutes 20% of the inner monolayer (i.e., 9% of total
bilayer lipid), these results imply that 1-2% of total
membrane lipid participates in this exchange. Implicit to
this estimate are the assumptions that (a) translocation of
lipid between monolayers occurs by one-for-one
exchange, and (b) pyrenePC and unlabeled lipid are
equivalent in the transbilayer exchange process (see
Materials and Methods). This transbilayer exchange of
phospholipid commences immediately upon C8 addition
and is complete within 40-60 s at 370C (see Fig. 7),
approximating the kinetics of C8 binding and activation
of the functional complement pore observed at this tem-
perature (30, 31). Assuming a random distribution of
preassembled C5b67 complexes among ALUV, these
data suggest that transbilayer exchange of phospholipid is
related to the incorporation of C8 into the membrane
C5b-8 complex, and that this transbilayer migration of
lipid is only transiently activated, resulting in net
exchange of only a small fraction of total membrane
phospholipid. This implies that transbilayer migration of
lipid occurs only during insertion of C8 into the mem-
brane, and is likely to be localized to the vicinity of the
bound C5b-8 complex.
One surprising result of the present study was that we
were unable to detect any difference in the amount of
transbilayer migration of pyrenePC upon C8 vs. C8 + C9
interaction with membrane C5b67 (cf. Table 2 and
Fig. 6). These results imply that most of the alteration in
bilayer phospholipid asymmetry arising from assembly of
these proteins occurs upon binding of C8, and not upon
incorporation of C9 (and C9 polymer) into the membrane
attack complex. Although we cannot exclude the possibil-
ity that the C5b6-C8 proteins we employed in this study
were contaminated with trace quantities of C9 sufficient
to induce the observed changes in phospholipid asymme-
try, we consider this possibility unlikely based on the
following considerations. First, we have been unable to
detect functional C9 (by hemolytic assay; 22-24) in these
proteins when prepared as described in Materials and
Methods. Furthermore, we observe no change in the
measured response to C8 (added to C5b67 ALUV) for
protein repeatedly absorbed against monospecific anti-
body to C9 (data not shown). In this context it is of
interest to note that (a) although acyl chain restricted
photoaffinity probes show minimal labeling of protein in
the membrane C5b67 complex, addition of C8 results in
marked photolabeling of both the a- and y-chains of this
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protein, suggesting peptide insertion into the bilayer upon
C8 binding (32-34); (b) measurement of phospholipid
binding to the C5b-9 proteins suggest that the C5b-8
complex expresses 80% of the phospholipid binding sites
exhibited by the C5b-9 complex (35); (c) analysis of
electron spin resonance spectra obtained with oriented
lipid multimers indicates that a large change in acyl chain
organization occurs upon C8 binding to C5b67, account-
ing for -50% of the spectral change observed for the fully
assembled C5b-9 complex (14); and (d) the C5b-8 com-
plex has been shown to lower the activation energy for
membrane insertion and polymerization of C9 (36, 37).
As has been suggested by Esser and associates
(14, 38, 39), one explanation for this effect of the mem-
brane-inserted C5b-8 complex on C9 activation may
relate to the capacity of this complex to create a focal
defect in lipid packing, promoting insertion of hydro-
phobic domains of C9 into the membrane.
It is of interest to note that in addition to these data for
the C5b-9 proteins, there is evidence that other pore-
forming molecules enhance the rate of transbilayer
migration of phospholipid, potentially through the forma-
tion of local domains of nonbilayer lipid (40, 41). For
example, Classen et al. (41) have recently shown that
incorporation of gramicidin into the membrane of human
erythrocytes enhances the rates of transbilayer migration
and that this enhancement was accompanied by the
formation of hexagonal HI, lipid structures. As suggested
by Cullis and De Kruijff (42), reversible formation of
nonbilayer structures in the membrane would provide a
mechanism for translocation of lipid between monolayers.
As indicated above, there is data suggesting that a local
disruption of bilayer structure occurs upon C8 insertion
into the membrane, which may account for the transbi-
layer exchange of phospholipid we observe upon C5b-8
assembly. The possibility that the increased membrane
permeability to aqueous solute arising upon insertion of
these proteins may also be related to formation of
domains of nonbilayer structure has been discussed previ-
ously (14, 43).
Finally, it should be noted that the well-known capacity
of the C5b-9 proteins to increase membrane permeability
(and ultimately lyse cell membranes) complicates the
interpretation of any results relating transbilayer asym-
metry that might be obtained using techniques which rely
upon exclusion of an aqueous component from the inter-
nal compartment. This includes methods that rely upon
chemical labeling of phospholipid head groups (44, 45),
phospholipase cleavages (46, 47), and the use of fluores-
cence quenching and nuclear magnetic resonance shift
reagents (48, 49). By using a phospholipid probe which is
itself asymmetrically distributed across the bilayer, the
method we have employed circumvents potential artifacts
arising from changes in membrane permeability. As
shown above this technique is extremely sensitive to
transbilayer migration of the labeled lipid, enabling ready
detection of the translocation of <0.1% of pyrenePC. We
suggest that future application of this method to analysis
of membrane composition asymmetry in other circum-
stances of altered membrane permeability be considered.
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